RSS

Aptamer Group

Biotechnology companies Aptamer Group and Valitacell are working together to develop a next-generation screening platform for drug development, the companies have announced. Read more

News

Biotechnology company Aptamer Group is collaborating with AstraZeneca to develop drug delivery devices targeting the kidney. Read more

News

Aptamer Group — a biotech business — has closed its Series A financing round, securing $2.2 million from overseas investors to support its aptamer development programme. Read more

News